Gradient diffusion antibiotic susceptibility testing of potentially probiotic lactobacilli

Journal of Food Protection

Volumn 64, Issue 12, 2001, Pages 2007-2014

  Charteris, W P ^a   Kelly, P M ^b   Morelli, L ^c   Collins, J K ^d  

^a SET Consultants Ltd   (Ireland)

^b ANIMAL AND GRASSLAND RESEARCH AND INNOVATION CENTRE   (Ireland)

^c UNIVERSITÀ CATTOLICA DEL SACRO CUORE   (Italy)

^d UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA (MICROORGANISMS); LACTOBACILLUS; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS REUTERI; LACTOBACILLUS RHAMNOSUS;

ANTIBIOTIC AGENT; PROBIOTIC AGENT;

ARTICLE; CULTURE MEDIUM; DAIRY PRODUCT; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; IMMUNODIFFUSION; LACTOBACILLUS; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MULTIDRUG RESISTANCE;

ANTIBIOTICS; CULTURE MEDIA; DAIRY PRODUCTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; IMMUNODIFFUSION; LACTOBACILLUS; MICROBIAL SENSITIVITY TESTS; PROBIOTICS; SUPPORT, NON-U.S. GOV'T;

EID: 0035542805     PISSN: 0362028X     EISSN: None     Source Type: Journal    
DOI: 10.4315/0362-028X-64.12.2007     Document Type: Article

References (100)

1. Lactic acid bacteria and human clinical infection
2. Antimicrobial susceptibility testing in Sweden
3. Multilaboratory evaluation of the agar diffusion disk susceptibility test for rapidly growing anaerobic bacteria
4. Relatedness of Lactobacillus rhamnosus strains isolated from clinical specimens and such from foodstuffs, humans, and technology
5. Lactobacillaemia - Report of nine cases
6. Therapy of experimental infective endocarditis due to antibiotic-tolerant Lactobacillus plantarum - Bactericidal synergy of penicillin plus gentamicin. Correlation of in vitro susceptibility studies with in vivo efficacy
7. Bactericidal synergy between penicillin or ampicillin and aminoglycosides against antibiotic-tolerant lactobacilli
8. Treatment of relapsing Clostridium difficile diarrhea with Lactobacillus GG
9. Treatment of recurrent Clostridium difficile colitis with Lactobacillus GG
10. Modification of petidoglycan precursors is a common feature of the low-level vancomycin resistant VanB-type enterococcus D366 and of the naturally glycopeptide-resistant species Lactobacillus casei, Pediococcus pentosaceus, Leuconostoc mesenteroides and Enterococcus gallinarum
11. Evaluation of the E-test: A novel method of quantifying antimicrobial activity
12. A standard agar overlay disc diffusion method to determine the antibiotic susceptibility of facultative anaerobic Lactobacillus and Bifidobacterium species
13. The role and therapeutic potential of Lactobacillus species in female urogenital tract infection
14. Selective detection, enumeration and identification of potentially probiotic Lactobacillus and Bifidobacterium species in mixed bacterial populations
15. Antibiotic susceptibility of potentially probiotic Lactobacillus species
16. Ingredient selection criteria for probiotic micro-organisms in functional dairy foods
17. Development of an agar overlay disc diffusion method for antibiotic susceptibility testing of potentially probiotic Lactobacillus and Bifidobacterium species
18. Effect of conjugated bile salts on antibiotic disc susceptibility of potentially probiotic Lactobacillus and Bifidobacterium isolates
19. Edible table (bio)spread containing potentially probiotic Lactobacillus and Bifidobacterium species
20. Quality control Lactobacillus strains for use with the API 50CH and API ZYM systems at 37°C
21. Lactobacillus casei subspecies casei endocarditis - A case report
22. Cytolytic vaginosis
23. Deoxyribonucleic acid homology studies of Lactobacillus casei, Lactobacillus paracasei sp. nov., subsp. paracasei and subsp. tolerans and Lactobacillus rhamnosus sp. nov., comb. nov.
24. Aerobic metabolism of lactic acid bacteria
25. Lactobacillus sepsis with pelvic abscess
26. Antibiotic-induced D-lactic acidosis
27. Evaluation of the E test for antimicrobial spectrum and potency determinations of anaerobes associated with bacterial vaginosis and peritonitis
28. A medium for the cultivation of lactobacilli
29. Lactobacillus gasseri as a cause of septic urinary infection
30. Reclassification of Lactobacillus casei subsp. casei ATCC 393 and Lactobacillus rhamnosus ATCC 15820 as Lactobacillus zeae nom. rev., designation of ATCC 334 as the neotype of L. casei subsp. casei, and rejection of the name Lactobacillus paracasei
31. Simple identification of anaerobic bacteria to genus level using typical antibiotic susceptibility patters
32. 2 production, and antibiotic resistance and correlation with human clinical status
33. Metronidazole: A therapeutic review and update
34. Lactobacillus fermentum endocarditis involving a native mitral valve
35. Safety of lactic acid bacteria and their occurrence in human clinical infections
36. Health benefits of probiotics
37. The discovery of Lactobacillus GG
38. Successful treatment of relapsing Clostridium difficile colitis with Lactobacillus GG
39. Two cases of endocarditis due to Lactobacillus species: Antimicrobial susceptibility, review, and discussion of therapy
40. Vancomycin susceptibility as an aid to the identification of lactobacilli
41. New species-related MIC breakpoints for early detection of development of resistance among gram-negative bacteria in Swedish intensive care units
42. Vancomycin-resistant Leuconostoc mesenteroides and Lactobacillus casei synthesize cytoplasmic peptidoglycan precursors that terminate in lactate
43. Pathogenic potential of lactobacilli
44. Vancomycin resistance of clinical isolates of lactobacilli
45. Lactobacillaemia in three patients with AIDS
46. Vaginal lactobacillosis
47. Trimethoprim and sulphonamide resistance
48. Resistance to vancomycin and teicoplannin: An emerging clinical problem
49. Lactobacillus rhamnosus infection in a child following bone marrow transplant
50. Intra-species characterisation of clinical isolates and biotechnotogically used strains of Lactobacillus rhamnosus by analysis of the total soluble cytoplasmic proteins with silver staining
51. Exclusion of vanA, vanB and vanC type glycopeptide resistance in strains of Lactobacillus reuteri and Lactobacillus rhamnosus used as probiotics by polymerase chain reaction and hybridisation methods
52. Peritonitis associated with vancomycin-resistant Lactobacillus rhamnosus in a continuous ambulatory peritoneal dialysis patient: Organism identification, antibiotic therapy, and case report
53. The relationship between the capsular and cell wall polysaccharides of strains of Lactobacillus casei subsp. rhamnosus
54. Lactobacillus rhamnosus GG (ATCC 53103) and platelet aggregation in vitro
55. Enzyme profile of Lactobacillus strain GG by a rapid API ZYM system: A comparison of intestinal bacterial strains
56. Clones of Lactobacillus casei and Torulopsis glabrata associated with recurrent abdominal wall abscess
57. Persistent Lactobacillus casei subspecies rhamnosus bacteremia in a 14 year old girl with acute myeloid leukemia. A case report
58. Susceptibility of female pelvic pathogens to oral antibiotic agents in patients who develop postpartum endometritis
59. Fatal lung absecess due to Lactobacillus casei subsp. rhamnosus
60. Novel method for detection of β-lactamases by using a chromogenic cephalosporin substrate
61. Use of 16S rRNA gene sequencing to identify Lactobacillus casei in septicaemia secondary to a paraprosthetic enteric fistula
62. Lactobacillaemia in liver transplant patients
63. Antibiotic-disc tests for rapid identification of non-sporing anaerobes
64. Tests for bactericidal effects of antimicrobial agents: Technical performance and clinical relevance
65. A guide to sensitivity testing
66. Liver abscess due to a Lactobacillus rhamnosus strain indistinguishable from L. rhamnosus strain GG
67. Assessment of safety and efficacy of functional foods and ingredients
68. Functional food science and gastrointestinal physiology and function
69. Lactobacillus GG (Gefilac™ fermented whey drink and yoghurt
70. Lactobacillus GG - A human probiotic strain with thorough clinical documentation
71. Impact of a lactobacillus probiotic on the faecal microflora in children with shigellosis
72. Pathogenic lactobacilli
73. Lactobacillus plantarum endocarditis
74. Effects of following National Committee for Clinical Laboratory Standards and Deutsche Industrie Norm-Medizinische Mikrobiologie guidelines, country of isolate origin, and site of infection on suceptibility of Escherichia coli to amoxicillin-calvulanate (augmentin)
75. A pathogenic lactobacillus
76. Deep seeded infection due to Lactobacillus casei
77. Susceptibilities of 201 anaerobes to erythromycin, azithromycin, clarithromycin, and roxithromycin to oxyrase agar dilution and E test methodologies
78. Isolation of vancomycin-resistant lactobacilli from three neutropenic patients with pneumonia
79. Antimicrobial susceptibility testing within the clinic
80. Comparison of ribotyping, randomy amplified polymorphic DNA analysis, and pulsed-field gel electrophoresis in typing Lactobacillus rhamnosus and L. casei strains
81. Vancomycin resistance factor of Lactobacillus rhamnosus GG in relation to enterococcal vancomycin resistance (van) genes
82. The ecology of the human intestine and its consequences for overgrowth by pathogens such as Clostridium difficile
83. Development and persistence of multi-resistance to antibiotics in bacteria: An analysis and a new approach to this urgent problem
84. Lactobacillus casei endocarditis in an intravenous heroin drug addict: A case report
85. Functions and activities of the area committee on microbiology of the National Committee for Clinical Laboratory Standards
86. Haemagglutination activity of Lactobacillus acidophilus group lactic acid bacteria